158 related articles for article (PubMed ID: 1369829)
1. Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.
Blazar BR; Widmer MB; Taylor PA; Vallera DA
Blood; 1992 Sep; 80(6):1614-22. PubMed ID: 1369829
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.
Blazar BR; Aukerman SL; Vallera DA
Blood; 1992 Mar; 79(6):1636-42. PubMed ID: 1547353
[TBL] [Abstract][Full Text] [Related]
3. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
Shatry AM; Jones M; Levy RB
Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
[TBL] [Abstract][Full Text] [Related]
4. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
[TBL] [Abstract][Full Text] [Related]
5. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
6. In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation.
Atkinson K; Matias C; Guiffre A; Seymour R; Cooley M; Biggs J; Munro V; Gillis S
Blood; 1991 Mar; 77(6):1376-82. PubMed ID: 1705839
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 alpha-mediated promotion of long-term alloengraftment and short-term neutrophil expansion does not require the presence of either donor or host T cells.
Vallera DA; Taylor PA; Widmer MB; Blazar BR
Transplantation; 1996 Sep; 62(5):636-42. PubMed ID: 8830829
[TBL] [Abstract][Full Text] [Related]
8. Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens.
Blazar BR; Taylor PA; Bluestone JA; Vallera DA
Blood; 1996 May; 87(10):4463-72. PubMed ID: 8639809
[TBL] [Abstract][Full Text] [Related]
9. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
10. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.
Fibbe WE; Heemskerk DP; Laterveer L; Pruijt JF; Foster D; Kaushansky K; Willemze R
Blood; 1995 Nov; 86(9):3308-13. PubMed ID: 7579432
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.
Blazar BR; Widmer MB; Soderling CC; Urdal DL; Gillis S; Robison LL; Vallera DA
Blood; 1988 Feb; 71(2):320-8. PubMed ID: 3276361
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
Wu DD; Nayar R; Keating A
Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
[TBL] [Abstract][Full Text] [Related]
13. Improved survival and marrow engraftment of mice transplanted with bone marrow of GM-CSF-treated donors.
Ballin A; Sagi O; Schiby G; Meytes D
Eur J Haematol; 1993 Mar; 50(3):168-71. PubMed ID: 8472812
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
Blazar BR; Taylor PA; Smith S; Vallera DA
Blood; 1995 Feb; 85(3):842-51. PubMed ID: 7833486
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice.
Drobyski WR; Majewski D
Blood; 1997 Feb; 89(3):1100-9. PubMed ID: 9028343
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
[TBL] [Abstract][Full Text] [Related]
20. Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells.
Fibbe WE; Hamilton MS; Laterveer LL; Kibbelaar RE; Falkenburg JH; Visser JW; Willemze R
J Immunol; 1992 Jan; 148(2):417-21. PubMed ID: 1345921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
